PDCD1 and neoplasm: Moreover, another anti-human PD-1 inhibitor (nivolumab) has been tested in ovo and induced significant tumor growth inhibition at 2 mg/kg on this tumor model (p = 0.0031) (Figure 9c), without leading to evident mortality (Figure 9d).